Ethris GmbH

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Oak Hill Licenses Roche’s Rugonersen,

Cipla Limited , which is sitting on a sizeable cash kitty, continues to scan the deal horizon both in India and the US, among other markets, alongside exploring opportunities in new therapeutic areas

Cipla Limited , which is sitting on a sizeable cash kitty, continues to scan the deal horizon both in India and the US, among other markets, alongside exploring opportunities in new therapeutic areas

The year gone by saw India Pharma Inc scale new peaks in terms of cutting-edge R&D advances but there were perilous valleys as well as quality issues hit hard, threatening to eclipse the industry’s re